Fig. 6From: LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathwayThe schematic diagram indicating that CBR3-AS1 and JNK1 / MEK4 competitively bind to miR-25-3p, thus regulating MAPK signaling pathway to promote drug resistance of breast cancer cellsBack to article page